HRS9531
Drug timelines are a Plus or Pro feature.
22 regulatory and trial events tracked for HRS9531, covering 2023-09-26 to 2026-07-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes [Phase 3]